Suzuken Co., Ltd. (TYO:9987)

Market Cap	355.50B -17.2%
Revenue (ttm)	2.52T +4.7%
Net Income	37.74B +13.3%
EPS	548.08 +22.5%
Shares Out	67.64M
PE Ratio	9.59
Forward PE	14.47
Dividend	120.00 (2.33%)
Ex-Dividend Date	Sep 29, 2026

Volume	28,700
Open	5,295.00
Previous Close	5,256.00
Day's Range	5,217.00 - 5,295.00
52-Week Range	4,770.00 - 6,668.00
Beta	0.23
Analysts	Buy
Price Target	6,023.33 (+15.17%)
Earnings Date	Nov 12, 2026

About Suzuken

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, Specialty Drug Contract Distribution, and Healthcare Related Services. The Pharmaceutical Distribution Business segment purchases ethical drugs, diagnostic agents, medical equipment, medical materials, and medical food products, as well as pharmaceutical and medica...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1932
• Employees: 12,717
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9987

Financial Performance

In fiscal year 2026, Suzuken's revenue was 2.49 trillion, an increase of 3.61% compared to the previous year's 2.40 trillion. Earnings were 38.14 billion, an increase of 10.55%.

Analyst Summary

According to 3 analysts, the average rating for 9987 stock is "Buy." The 12-month stock price target is ¥6,023, which is an increase of 15.17% from the latest price.

Price Target

¥6,023

(15.17% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 15, 2026

Data Sources Report a data error